Skip to main content
. 2017 Jun 14;37(24):5834–5845. doi: 10.1523/JNEUROSCI.3680-16.2017

Table 1.

Arterial PCO2, PO2 and mean arterial pressure during baseline, the first hypoxic episode, and 60 min following AIH in end-stage SOD1G93A rats and wild-type littermates

Experimental groups PaCO2 (mmHg)
PaO2 (mmHg)
Mean arterial pressure (mmHg)
Baseline Hypoxia 60 min Baseline Hypoxia 60 min Baseline Hypoxia 60 min
With AIH
    siNT
        Wild-type 52.5 ± 1.5 52.6 ± 1.6 52.5 ± 1.8 325 ± 5a,b,f 40.7 ± 1.0g 296 ± 19a,f 116 ± 9a 75 ± 8f,g 111 ± 8a,f
        SOD1G93A 51.0 ± 1.8a 52.5 ± 2.0 51.5 ± 1.5 334 ± 8a 42.6 ± 2.2h 325 ± 9a 98 ± 7a 71 ± 6h 95 ± 7a
    siBDNF
        Wild-type 52.5 ± 1.6 51.7 ± 1.8 53.0 ± 1.7a 313 ± 9a,f 38.8 ± 0.8g 304 ± 7a,f 112 ± 6a,b 65 ± 4g 99 ± 6a
        SOD1G93A 51.2 ± 0.6 50.8 ± 0.7 51.2 ± 0.9 329 ± 4a 40.5 ± 0.6h 316 ± 7a 112 ± 8a 71 ± 7h 100 ± 8a
    siTrkB
        Wild-type 54.1 ± 1.7 54.3 ± 1.6 54.5 ± 1.8 299 ± 20a,f 37.5 ± 1.0g 285 ± 20a,f 117 ± 4a 72 ± 4f,g 108 ± 4a
        SOD1G93A 52.8 ± 1.5 52.4 ± 1.4 52.7 ± 1.9 318 ± 8a 38.1 ± 1.4h 290 ± 13a 92 ± 21a,b 67 ± 12h 85 ± 12a
    Vehicle
        Wild-type 50.9 ± 1.5a 49.7 ± 1.5d 51.3 ± 1.5a 292 ± 9a,f 37.4 ± 1.3g 267 ± 15a,f 98 ± 6a,d 58 ± 8g,j 92 ± 6a,d,j
        SOD1G93A 50.6 ± 1.8 50.7 ± 1.8 50.9 ± 2.0 308 ± 12a 36.6 ± 1.2h 293 ± 15a 97 ± 4a,b,h 56 ± 5h 77 ± 5a,h,i
    UO126
        Wild-type 48.8 ± 1.0d 48.5 ± 1.3d 49.0 ± 1.0d 303 ± 8a,b,f 37.1 ± 2g 272 ± 18a,f 99 ± 5a,b,d 70 ± 11f,g 84 ± 3a,d,j
        SOD1G93A 49.9 ± 1.4 49.4 ± 1.5 49.7 ± 1.3 285 ± 16a,e 39.2 ± 1.9h 271 ± 16a,e 97 ± 3a,b 53 ± 5h 78 ± 8a,h,i
    PI828
        Wild-type 51.4 ± 1.2a 49.9 ± 1.4d 51.2 ± 1.0a 230 ± 21a 36.8 ± 1.3g 220 ± 19a,g 106 ± 4a,b 50 ± 4g 88 ± 3a,d
        SOD1G93A 51.6 ± 2.0 51.2 ± 1.8 52.2 ± 2.1a 292 ± 20a,b,f 38.3 ± 1.5h 256 ± 25a,e,f,h,i 94 ± 5a,b 54 ± 4h 82 ± 4a
Without AIH (TCs)
    Wild-type 50.0 ± 0.9 49.9 ± 1.0d 50.2 ± 0.8d 297 ± 14f 295 ± 15 282 ± 17 105 ± 4 104 ± 4 98 ± 4c
    SOD1G93A 49.7 ± 1.4 49.7 ± 1.6 48.8 ± 1.5a,c 316 ± 8 305 ± 13 299 ± 10 112 ± 5a,b 108 ± 5 95 ± 4

Data are for rats with AIH or without AIH. Rats received intrathecal injections of either (1) siRNAs targeting BDNF (siBDNF), TrkB (siTrkB), or nontarget (siNT) mRNA; or (2) vehicle or inhibitors for MEK/ERK (UO126) or PI3K/Akt (PI828). Significant differences within individual study groups are indicated as follows:

asignificant difference from hypoxia,

bsignificant difference from 60 min, and

csignificant difference from baseline. Significant differences across study groups are indicated as follows:

dsignificant difference from wild-type siTrkB,

esignificant difference from SOD1G93A siNT,

fsignificant difference from wild-type PI828,

gsignificant difference from wild-type without AIH,

hsignificant difference from SOD1G93A without AIH,

isignificant difference from SOD1G93A siBDNF, and

jsignificant difference from wild-type siNT. Values are expressed as means ± 1 SEM. Differences were considered significant if p < 0.05.